🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Michael J. Hochman

Emory University

ORCID: 0000-0003-0594-154X

Also affiliated with Piedmont Cancer Institute, Winship Cancer Institute

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Systematic improvements in lentiviral transduction of primary human natural killer cells undergoing ex vivo expansion”.

Systematic improvements in lentiviral transduction of primary human natural killer cells undergoing ex vivo expansion

Molecular Therapy — Methods & Clinical Development(2021)10.1016/j.omtm.2021.01.008

N/A

0.617DataRank · unranked

60 citations

Mala Chakraborty, Giacomo Waller, Michael J. Hochman, Akkapon Poolcharoen, Robert Reger +2 more

Myelodysplastic syndrome and autoimmune disorders: two sides of the same coin?

The Lancet Haematology(2022)10.1016/s2352-3026(22)00138-7

N/A

0DataRank · unranked

51 citations

Amy E. DeZern, Michael J. Hochman

Precision Medicine in Myeloid Neoplasia: Challenges and Opportunities

Journal of Personalized Medicine(2025)10.3390/jpm15020049

N/A

0DataRank · unranked

4 citations

Joshua P. Muñiz, Nikolaos Papadantonakis, Michael J. Hochman